Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs

NANot yet recruitingINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Upper Respiratory Tract Infection
Interventions
DEVICE

FeverApp

The (self-management) FeverApp contains evidence-based information about fever and how to deal with it, tailored (phase-oriented) fever advices, and the option to monitor the health status of the child during a fever episode. All information and advices are based on the clinical expertise of paediatricians and the most recent international literature on fever, and complement the Dutch national fever guidelines. It is expected that by letting the body fight the infection on its own in a safe way, less ABs are needed, and the immune system will get stronger leading to less future infections as well.

DEVICE

DMT App

The (self-care) DMT App is a decision making tool (DMT) that can be used by parents to choose a safe and effective herbal medicine (HM) product to reduce symptoms of mild, acute uncomplicated URTIs in their child. The advices that the DMT App provides, are based on a systematic review (SR) of SRs on effectiveness of HM for URTIs, a SR on working mechanisms of the most promising herbs, a prescription rates study of HM for URTIs in 6 European countries, and current EMA status of the included herbs. No prescription from a doctor is needed for these products.

Trial Locations (1)

Unknown

Amsterdam UMC location AMC, Amsterdam

All Listed Sponsors
lead

Max Nieuwdorp

OTHER

NCT06140446 - Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs | Biotech Hunter | Biotech Hunter